Vaccinations Increase by 47,000... 328 Additional Adverse Reactions Reported (Update)

[Asia Economy Reporter Choi Dae-yeol] The COVID-19 vaccination task force announced on the 2nd that the number of people newly vaccinated reached 46,881 (combined first and second doses). There were 39,169 new first-dose recipients, bringing the total number of people who have received the first dose to approximately 3,395,000, and 7,712 new second-dose recipients, with a total of about 236,000 people having completed their vaccinations. The vaccination rate relative to the population is 6.6% for the first dose and 0.5% for the second dose.

The number of reported suspected adverse reactions after vaccination increased by 328 cases, totaling 16,524 cases so far. This accounts for about 0.46% of the cumulative vaccinated population. Among the newly reported cases, there were 4 death reports: 3 related to the Pfizer vaccine and 1 related to the AstraZeneca vaccine. Causality between vaccination and death has not yet been confirmed.

One additional suspected case of anaphylaxis, a severe systemic allergic reaction, was reported. This case involved a recipient of the AstraZeneca vaccine. There were 2 severe suspected cases involving seizures and intensive care unit admissions, both related to the Pfizer vaccine. The remaining 321 cases were mild symptoms commonly observed after vaccination, such as muscle pain, headache, fever, chills, and nausea.

Among all suspected adverse reaction reports, 14,204 cases were related to the AstraZeneca vaccine and 2,320 cases to the Pfizer vaccine. The reporting rate relative to vaccinations is 0.78% for AstraZeneca and 0.13% for Pfizer. To date, there have been a total of 79 reported deaths related to adverse reactions in Korea (44 for AstraZeneca and 35 for Pfizer). These are cases reported as deaths at the time of adverse reaction reporting; cases initially reported as mild but later worsening to death are excluded.

This content was produced with the assistance of AI translation services.